The Oncology Institute, Inc. (TOIIW) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.29B |
| Enterprise Value | 3.36B |
| P/E Ratio | -13.89 |
| PEG Ratio | -0.2 |
| Price/Sales Ratio | 0.89 |
| Price/Book Ratio | -303.81 |
| Enterprise/Revenue | 1.03 |
| Enterprise/EBITDA | -19.18 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.08 |
| Operating Margin | -0.06 |
AD
Management Effectiveness
| Return On Assets | -0.26 |
| Return On Equity | 3.27 |
Income Statement
| Revenue | 502.73M |
| Revenue/Share | 0.54 |
| Gross Profit | 76.44M |
| EBITDA | -42.52M |
| Net Income | -60.61M |
| Diluted EPS | -0.54 |
Balance Sheet
| Total Cash | 30.28M |
| Total Cash/Share | 0.03 |
| Total Debt | 104.86M |
| Total Debt/Equity | -6.44 |
| Current Ratio | 1.47 |
| Book Value Per Share | -0.02 |
Price History
| 52-Week Change | -55.45 |
| 52-Week High | 0.18 |
| 52-Week Low | 0.05 |
| Moving Average 50 Days | 0.05 |
| Moving Average 200 Days | 0.1 |
Statistics
| Average Volume | 10,300 |
| Shares Outstanding | 98.57M |
| % Held by Institutions | 0.38 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
